20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MiniMed Group, Inc. Common Stock (MMED) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Northridge, United States with about 8,000 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2026-04-30, MMED reported $3.1B in revenue and ($331M) in net income.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
Interactive charts & full statements → Open the MMED valuation workbench →
| Income statement | TTM → 2026-07-31 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|---|
| Total Revenue | $3.2B | $3.1B | $2.7B | $2.5B | $2.2B |
| Gross Profit | $1.7B | $1.7B | $1.5B | $1.4B | $1.3B |
| Gross Margin % | 53.8% | 54.2% | 56.2% | 58.2% | 58.3% |
| Operating Income (EBIT) | ($188M) | $49M | ($202M) | ($69M) | ($69M) |
| Operating Margin % | -5.8% | 1.6% | -7.4% | -2.8% | -3.1% |
| Net Income | ($331M) | ($331M) | ($250M) | ($112M) | ($96M) |
| Net Margin % | -10.3% | -10.7% | -9.2% | -4.5% | -4.3% |
| EBITDA | — | $49M | $107M | $59M | $39M |
| Earnings Per Share (EPS) | — | $-1.29 | $-0.89 | $-0.40 | $-0.34 |
| Shares Outstanding (M) | — | 257M | 281M | 281M | 281M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|---|
| Total Revenue | $843M | $837M | $790M | $724M | $687M |
| Gross Profit | $465M | $480M | $362M | $402M | $395M |
| Gross Margin % | 55.2% | 57.4% | 45.8% | 55.5% | 57.5% |
| Operating Income (EBIT) | ($2M) | $82M | ($93M) | ($204M) | $22M |
| Operating Margin % | -0.2% | 9.8% | -11.8% | -28.2% | 3.2% |
| Net Income | $0M | ($183M) | ($119M) | ($209M) | ($10M) |
| Net Margin % | 0.0% | -21.9% | -15.1% | -28.9% | -1.5% |
| EBITDA | — | $82M | ($60M) | — | — |
| Earnings Per Share (EPS) | $0.00 | $-0.68 | $-0.42 | $-0.74 | — |
| Shares Outstanding (M) | — | 268M | 281M | 281M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-07-31 | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 |
|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($105M) | ($197M) | $140M | $41M | ($6M) |
| Capital Expenditures (CapEx) | $211M | $223M | $193M | $148M | $167M |
| Free Cash Flow (FCF) | ($316M) | ($420M) | ($53M) | ($107M) | ($173M) |
| FCF Margin % | -9.8% | -13.5% | -1.9% | -4.3% | -7.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($49M) | ($170M) | $66M | $83M | $24M |
| Capital Expenditures (CapEx) | $41M | $56M | $53M | $57M | $50M |
| Free Cash Flow (FCF) | ($90M) | ($226M) | $13M | $26M | ($26M) |
| FCF Margin % | -10.7% | -27.0% | 1.7% | 3.6% | -3.8% |
| Dividends Paid | — | $229M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-04-30 | 2026-04-30 | 2025-04-30 | 2024-04-30 |
|---|---|---|---|---|
| Total Assets | $4.6B | $4.6B | $4.2B | $4.1B |
| Cash & Cash Equivalents | $298M | $298M | $11M | $54M |
| Total Liabilities | $1.0B | $1.0B | $870M | $646M |
| Total Debt (Short + Long-Term) | $145M | $145M | $11M | $8M |
| Total Shareholders' Equity | $3.6B | $3.6B | $3.3B | $3.4B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MMED viewer.
About TickerBase · Data methodology & sources · Privacy · Terms